214 related articles for article (PubMed ID: 19954394)
1. Severe atopic dermatitis treated with everolimus.
Van Velsen SG; Haeck IM; Bruijnzeel-Koomen CA
J Dermatolog Treat; 2009; 20(6):365-7. PubMed ID: 19954394
[TBL] [Abstract][Full Text] [Related]
2. Severe psoriasis treated with a new macrolide: everolimus.
Frigerio E; Colombo MD; Franchi C; Altomare A; Garutti C; Altomare GF
Br J Dermatol; 2007 Feb; 156(2):372-4. PubMed ID: 17223881
[TBL] [Abstract][Full Text] [Related]
3. Safety, tolerability, and efficacy of everolimus in de novo liver transplant recipients: 12- and 36-month results.
Levy G; Schmidli H; Punch J; Tuttle-Newhall E; Mayer D; Neuhaus P; Samuel D; Nashan B; Klempnauer J; Langnas A; Calmus Y; Rogiers X; Abecassis M; Freeman R; Sloof M; Roberts J; Fischer L
Liver Transpl; 2006 Nov; 12(11):1640-8. PubMed ID: 16598777
[TBL] [Abstract][Full Text] [Related]
4. Adherence must always be considered: is everolimus really ineffective as a treatment for atopic dermatitis?
Feldman SR
J Dermatolog Treat; 2009; 20(6):317-8. PubMed ID: 19954385
[No Abstract] [Full Text] [Related]
5. Long-term results of kidney transplantation with cyclosporine- and everolimus-based immunosuppression.
Iaria G; Pisani F; Iorio B; Lucchesi C; De Luca L; Ielpo B; D'Andria D; Tariciotti L; Tisone G
Transplant Proc; 2006 May; 38(4):1018-9. PubMed ID: 16757249
[TBL] [Abstract][Full Text] [Related]
6. First experience with enteric-coated mycophenolate sodium (Myfortic) in severe recalcitrant adult atopic dermatitis: an open label study.
van Velsen SG; Haeck IM; Bruijnzeel-Koomen CA; de Bruin-Weller MS
Br J Dermatol; 2009 Mar; 160(3):687-91. PubMed ID: 19120337
[TBL] [Abstract][Full Text] [Related]
7. Everolimus and reduced cyclosporine trough levels in maintenance heart transplant recipients.
Schweiger M; Wasler A; Prenner G; Stiegler P; Stadlbauer V; Schwarz M; Tscheliessnigg K
Transpl Immunol; 2006 Jun; 16(1):46-51. PubMed ID: 16701176
[TBL] [Abstract][Full Text] [Related]
8. 12-month safety and efficacy of everolimus with reduced exposure cyclosporine in de novo renal transplant recipients.
Tedesco-Silva H; Vitko S; Pascual J; Eris J; Magee JC; Whelchel J; Civati G; Campbell S; Alves-Filho G; Bourbigot B; Garcia VD; Leone J; Esmeraldo R; Rigotti P; Cambi V; Haas T;
Transpl Int; 2007 Jan; 20(1):27-36. PubMed ID: 17181650
[TBL] [Abstract][Full Text] [Related]
9. Clinical experience with Certican (everolimus) in de novo heart transplant patients at the Deutsches Herzzentrum Berlin.
Lehmkuhl H; Hetzer R
J Heart Lung Transplant; 2005 Apr; 24(4 Suppl):S201-5; discussion S210-1. PubMed ID: 15774323
[TBL] [Abstract][Full Text] [Related]
10. From clinical trials to clinical practice: an overview of Certican (everolimus) in heart transplantation.
Valantine H; Zuckermann A
J Heart Lung Transplant; 2005 Apr; 24(4 Suppl):S185-90; discussion S210-1. PubMed ID: 15774320
[TBL] [Abstract][Full Text] [Related]
11. Tolerability and steady-state pharmacokinetics of everolimus in maintenance renal transplant patients.
Budde K; Neumayer HH; Lehne G; Winkler M; Hauser IA; Lison A; Fritsche L; Soulillou JP; Fauchald P; Dantal J;
Nephrol Dial Transplant; 2004 Oct; 19(10):2606-14. PubMed ID: 15316094
[TBL] [Abstract][Full Text] [Related]
12. Recommendations for use of Certican (everolimus) after heart transplantation: results from a German and Austrian Consensus Conference.
Hummel M
J Heart Lung Transplant; 2005 Apr; 24(4 Suppl):S196-200; discussion S210-1. PubMed ID: 15774322
[TBL] [Abstract][Full Text] [Related]
13. Everolimus in clinical practice--renal transplantation.
Pascual J
Nephrol Dial Transplant; 2006 Jul; 21 Suppl 3():iii18-23. PubMed ID: 16815852
[TBL] [Abstract][Full Text] [Related]
14. Everolimus with reduced-dose cyclosporine in de novo renal transplant recipients: Philippine experience.
Li JT; Danguilan RA; Cabanayan-Casasola CB; Talusan-Tomacruz Y; Ona ET
Transplant Proc; 2008 Sep; 40(7):2211-3. PubMed ID: 18790195
[TBL] [Abstract][Full Text] [Related]
15. Low dose methotrexate therapy is effective in late-onset atopic dermatitis and idiopathic eczema.
Zoller L; Ramon M; Bergman R
Isr Med Assoc J; 2008 Jun; 10(6):413-4. PubMed ID: 18669134
[TBL] [Abstract][Full Text] [Related]
16. Comparing tacrolimus ointment and oral cyclosporine in adult patients affected by atopic dermatitis: a randomized study.
Pacor ML; Di Lorenzo G; Martinelli N; Mansueto P; Rini GB; Corrocher R
Clin Exp Allergy; 2004 Apr; 34(4):639-45. PubMed ID: 15080819
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporine reduction in the presence of everolimus: 3-month data from a Canadian pilot study of maintenance cardiac allograft recipients.
Ross H; Pflugfelder P; Haddad H; Cantarovich M; White M; Ignaszewski A; Howlett J; Vaillancourt M; Dorent R; Burton JR;
J Heart Lung Transplant; 2008 Feb; 27(2):197-202. PubMed ID: 18267227
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2-12 years: a double-blind, randomized, placebo-controlled trial.
Stainer R; Matthews S; Arshad SH; McDonald S; Robinson J; Schapira C; Foote KD; Baird-Snell M; Gregory T; Pollock I; Stevens MT; Edwards AM
Br J Dermatol; 2005 Feb; 152(2):334-41. PubMed ID: 15727648
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporin maintenance therapy for severe atopic dermatitis.
Korstanje MJ; van de Staak WJ
Acta Derm Venereol; 1991; 71(4):356-7. PubMed ID: 1681659
[TBL] [Abstract][Full Text] [Related]
20. Experience with everolimus.
Augustine JJ; Hricik DE
Transplant Proc; 2004 Mar; 36(2 Suppl):500S-503S. PubMed ID: 15041396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
